47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,9 | 1,4 | 0,8 | -41,4 |
EBITDA | 0,9 | 1,2 | 0,5 | -62,3 |
Short time liabilities | 4,5 | 5,3 | 5,8 | 10,2 |
Equity capital | 6,3 | 7,4 | 8 | 8,3 |
Operating profit (EBIT) | 0,9 | 1,1 | 0,4 | -64,1 |
Assets | 10,8 | 12,8 | 14,1 | 10,3 |
Net profit (loss) | 1 | 1,1 | 0,6 | -45,2 |
Cash | 2,6 | 3,5 | 4,1 | 17 |
Net income from sale | 22,3 | 28,2 | 31,7 | 12,4 |
Liabilities and provisions for liabilities | 4,5 | 5,3 | 6,1 | 13,2 |
Working assets | 6,1 | 8,1 | 9,4 | 16,1 |
Depreciation | 0,1 | 0,1 | 0,1 | -40,5 |
% | % | % | p.p. | |
Profitability of capital | 16 | 15,1 | 7,6 | -7,5 |
Equity capital to total assets | 58 | 58,1 | 57 | -1,1 |
Gross profit margin | 4,2 | 4,8 | 2,5 | -2,3 |
EBITDA Margin | 4,2 | 4,4 | 1,5 | -2,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 73 | 68 | 67 | -1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane